Luis González
About Luis González
Luis González is a Medical Science Manager specializing in immuno-oncology at Bristol-Myers Squibb in New York, with extensive experience in both academic and industry settings.
Title at Bristol-Myers Squibb
Luis González holds the position of Medical Science Manager specializing in immuno-oncology at Bristol-Myers Squibb. He is located in New York, New York, United States. His role focuses on the medical science aspects of immuno-oncology, leveraging his extensive background in clinical and academic research.
Professional Experience in Clinical Research
Before his current role, Luis González worked as a Clinical Research Associate (CRA) at Effice from 2014 to 2015. He also gained experience as a CRA trainee at the GEICAM Foundation in 2012 for seven months. His career in clinical research has provided him with substantial insights into the practical aspects of clinical trials and research management.
Academic Research Background
Luis González's career includes significant academic research experience. He was a predoctoral student at Universidad Alfonso X and Universidad de Vigo from 2012 to 2014. Earlier, he spent six months in 2010 as a predoctoral student at Universidad Complutense de Madrid. His academic background has been enriched by his roles in these prestigious institutions.
Education and Academic Qualifications
Luis González's educational journey includes multiple degrees from prominent institutions. He achieved several master's degrees from Universidad Autónoma de Madrid between 2005 and 2013. He also attained a bachelor's degree from UHasselt in 2010. His comprehensive education has provided him with a robust foundation in both medical science and research methodologies.
International Work Experience
Luis González has gained valuable international work experience in both Spain and the United States. His diverse career spans both academic and industry settings, showcasing his versatility and adaptability in various professional environments. This international exposure has allowed him to bring a global perspective to his current role at Bristol-Myers Squibb.